Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 10 of 317 for:    BENDAMUSTINE

Bendamustine in the Treatment of Chinese Patients With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01596621
Recruitment Status : Completed
First Posted : May 11, 2012
Last Update Posted : March 26, 2018
Sponsor:
Information provided by (Responsible Party):
Teva Pharmaceutical Industries ( Teva Branded Pharmaceutical Products, R&D Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 18, 2015
Actual Study Completion Date : April 28, 2017